Regular exercise reduces the risk of 7 different kinds of cancer

Regular exercise reduces the risk of 7 different kinds of cancer is been found out in a study conducted by American cancer society, The National Cancer Institute & Harvard T.H.Chan School of public health.

Share This Post

A study conducted in the US found that regular exercise reduces the risk of 7 different types of cancer. This study was conducted by the American Cancer Society, The National Cancer Institute, & Harvard T.Chan School of public health. This study was published in Journal of Clinical Oncology.

Purpose of the study

To determine whether recommended amounts of leisure-time physical activity (i.e, 7.5-15 metabolic equivalent task [MET] hours/week) are associated with lower cancer risk, describe the shape of the dose-response relationship, and explore associations with moderate- and vigorous-intensity physical activity.

Result of the study

A total of 755,459 participants (median age, 62 years [range, 32-91 years]; 53% female) were followed for 10.1 years, and 50,620 incident cancers accrued. Engagement in recommended amounts of activity (7.5-15 MET hours/week) was associated with a statistically significant lower risk of 7 of the 15 cancer types studied, including colon (8%-14% lower risk in men), breast (6%-10% lower risk), endometrial (10%-18% lower risk), kidney (11%-17% lower risk), myeloma (14%-19% lower risk), liver (18%-27% lower risk), and Non-Hodgkin lymphoma (11%-18% lower risk in women). The dose response was linear in shape for half of the associations and nonlinear for the others. Results for moderate- and vigorous-intensity leisure-time physical activity were mixed. Adjustment for body mass index eliminated the association with endometrial cancer but had limited effect on other cancer types.
Regular exercise was specially linked to :

  • An 8% lower risk of colon cancer in men for 7.5 MET hours per week and a 14% lower risk for 15 MET hours per week
  • A 6% lower risk of breast cancer in women for 7.5 MET hours per week and a 10% lower risk for 15 MET hours per week
  • A 10% lower risk of endometrial cancer in women for 7.5 MET hours per week and an 18% lower risk for 15 MET hours per week
  • An 11% lower risk of kidney cancer for 7.5 MET hours per week and a 17% lower risk for 15 MET hours per week
  • A 14% lower risk of multiple myeloma for 7.5 MET hours per week and a 19% lower risk for 15 MET hours per week
  • An 18% lower risk of liver cancer for 7.5 MET hours per week and a 27% lower risk for 15 MET hours per week
  • An 11% lower risk of Non-Hodgkin lymphoma in women for 7.5 MET hours per week and an 18% lower risk for 15 MET hours per week

So it is true that regular exercise is a very potent weapon for cancer prevention. The proven cancer types that can be prevented are Colon cancer, Breast cancer, Endometrial cancer, Kidney cancer, Multiple Myeloma, Liver cancer, Myeloma, Non-Hodgkin Lymphoma.
Just by walking 30 minutes a day reduces these risks tremendously.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

The future of gene therapy for genetic disorders
Treatment

Unlocking the genetic code: The future of gene therapy for genetic disorders

Gene therapy has typified the revolution in medicine that gives hope to various genetic disorders. This advanced treatment stops, and sometimes even reverses, the progress of a disease by the direct repair and replacement of defective genes. Trials and ethical dilemmas aside, this talent for transformation puts gene therapy right at the threshold of new frontiers in genetic medicine where inherited diseases might be eradicated altogether someday.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy